These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2760793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S, Iwamoto K, Hayashibara M, Katagiri Y.
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [Abstract] [Full Text] [Related]

  • 4. Salivary excretion of 5-fluorouracil (5-FU). V. Effect of 5-FU concentration in perfusate on the salivary excretion of 5-FU in perfused rat mandibular gland.
    Hayashi Y, Watanabe J.
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2008-11. PubMed ID: 2268905
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid.
    Joulia JM, Pinguet F, Ychou M, Duffour J, Astre C, Bressolle F.
    Eur J Cancer; 1999 Feb; 35(2):296-301. PubMed ID: 10448274
    [Abstract] [Full Text] [Related]

  • 7. Salivary excretion of mexiletine after bolus intravenous administration in rats.
    Nagasako S, Hayashibara M, Katagiri Y, Iwamoto K.
    J Pharm Pharmacol; 1992 Jan; 44(1):55-7. PubMed ID: 1350630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats.
    Watanabe J, Koyama I, Iwamoto K, Ozeki S.
    J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Excretion of indomethacin into saliva following intravenous administration to dogs.
    Watanabe J, Urasaki Y, Nakase Y, Ueda H, Iwamoto K, Ozeki S.
    J Pharmacobiodyn; 1981 May; 4(5):336-44. PubMed ID: 7288551
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL, Liang LJ, Hu WJ, Shen SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
    [Abstract] [Full Text] [Related]

  • 19. 5-Fluorouracil concentrations in rat plasma, parotid saliva, and bile and protein binding in rat plasma.
    Celio LA, DiGregorio GJ, Ruch E, Pace JN, Piraino AJ.
    J Pharm Sci; 1983 Jun; 72(6):597-9. PubMed ID: 6875817
    [Abstract] [Full Text] [Related]

  • 20. Biological monitoring of diazinon exposure using saliva in an animal model.
    Lu C, Irish RM, Fenske R.
    J Toxicol Environ Health A; 2003 Dec 26; 66(24):2315-25. PubMed ID: 14630523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.